Werewolf Therapeutics, Inc. HOWL
Set alert
As of Nov 3, 12:49 PM ET
- YTD
- +67.98%
- 1 year
- -18.70%
- Open
- 1.04
- Prev close
- 1.05
- Mkt cap
- 51.76M
- Vol
- 109.22K
- Avg vol
- 6.69M
- EPS
- -0.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.03
- High
- 1.07
- Forward P/E
- -0.86
- Beta
- 0.41
- Short ratio
- 2.09
- Inst. own
- 72.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.11
- 200-d avg
- 3.31
- 1y target
- 12.00
5D chart
Signals (64)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 9:55 AM | 3 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 3:55 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 3:40 PM | 21 hours ago |
| RSI: Overbought | Nov 2, 3:25 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 3:00 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 1:40 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 1:35 PM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 1:35 PM | 23 hours ago |
| RSI: Overbought | Nov 2, 1:15 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 11:45 AM | 1 day ago |
| MACD: Sell Signal | Nov 2, 10:45 AM | 1 day ago |
| SMA: Bullish | Nov 2, 9:45 AM | 1 day ago |
| RSI: Overbought | Nov 2, 9:45 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 3:45 PM | 3 days ago |
Newest 20 of 64.
News
-
4 days ago benzinga.com
Werewolf Therapeutics To Present Two Posters On WTX-124, WTX-330 Data At Upcoming SITC 2026 Annual Meeting
Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to…
4 days ago globenewswire.com
Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 2026 Annual Meeting
WALTHAM, Mass., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of…
6 days ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Neumora Therapeutics (NASDAQ:NMRA) shares rose 11.9% to $0.41 during Tuesday's after-market session. The market value of their outstanding shares is at $73.8 million. Pulmonx (NASDAQ:LUNG)…
3 weeks ago zacks.com
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
Werewolf Therapeutics (HOWL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
3 weeks ago zacks.com
New Strong Buy Stocks for October 9th
LITE, HOWL, PERI, GSBD and GFF have been added to the Zacks Rank #1 (Strong Buy) List on October 9th, 2026.
1 month ago defenseworld.net
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Stock Has Average Target Price of $4.00 According to Analysts
Shares of Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) have been assigned an average rating of "Hold" from the seven ratings firms that are currently covering the stock,…
1 month ago globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
BALA CYNWYD, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
1 month ago gurufocus.com
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders?
Are MKTX, HOWL, PSNL Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Sept. 9, 2026
1 month ago globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
2 months ago globenewswire.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ)
BALA CYNWYD, Pa., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky…
2 months ago gurufocus.com
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros Therapeutics, Inc. Upon clos
2 months ago businesswire.com
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros Therapeutics, Inc. Upon closing of the…
2 months ago gurufocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, TYFG and FULC
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, TYFG and FULC PR Newswire
2 months ago invezz.com
Why Werewolf Therapeutics stock exploded higher and what comes next?
Werewolf Therapeutics (HOWL) stock exploded higher on Friday morning after management said the company has agreed to a definitive all-stock merger with Ambros Therapeutics. The combined company will…
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares increased by 108.1% to $0.9 during Friday's regular session. The market value of their outstanding shares is at $20.9 million. Jupiter Neurosciences…
2 months ago benzinga.com
Gold Moves Higher; US Composite PMI Surges In August
Dow gains 400 points, Materials sector up 2.3%, Werewolf Therapeutics up 113%, S&P PMI rises to strongest level since April 2022.
2 months ago benzinga.com
Dow Jumps 350 Points; BJ's Wholesale Club Posts Upbeat Earnings
US stocks rise, Dow gains over 350 points as markets open Friday; Materials sector up 2%, utilities down 0.3%. BJ's Wholesale Club beats earnings expectations and raises guidance.
2 months ago benzinga.com
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.
2 months ago benzinga.com
One of Israel Englander's Biotech Picks Just Turned Into a $500M Merger Story
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) was one of the market's biggest pre-market movers on Friday after announcing a merger with Ambros Therapeutics.
2 months ago benzinga.com
One of Israel Englander's Biotech Picks Just Turned Into a $500M Merger Story
Werewolf Therapeutics surged after announcing a $500 million merger with Ambros Therapeutics, putting focus on Israel Englander's holding.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday's pre-market session. The company's market cap stands at $20.9 million. Jupiter Neurosciences…
2 months ago globenewswire.com
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
WALTHAM, Mass. and SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) and Ambros Therapeutics, Inc., today announced that they entered into a definitive merger…
2 months ago benzinga.com
Why Ross Stores Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI, HOWL, SUGP, SDEV, ZKH, BTAI, SXTC, TREO, and ASST. Losers are JZ, DFNS, FLUX, and MMA.
2 months ago benzinga.com
Werewolf Therapeutics (HOWL) Stock Is Trending Overnight—Here's Why It Jumped 90% After Hours
Werewolf Therapeutics shares surge 89.94% after hours as $33 million deal with EMD Serono brings fresh non-dilutive cash.
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million. Profusa (NASDAQ:PFSA) stock…
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
-
3 months ago benzinga.com
Werewolf Therapeutics Q2 EPS $0.08 Beats $(0.29) Estimate, Sales $21.000M
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.29) by 127.59 percent. This is a 120 percent increase over losses…
3 months ago globenewswire.com
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
WATERTOWN, Mass., July 31, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Tenet Healthcare (NYSE:THC) stock increased by 17.3% to $233.54 during Friday's regular session. The market value of their outstanding shares is at $17.4 billion. The company's, Q2 earnings…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
5 months ago benzinga.com
Why e.l.f. Beauty Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of elf Beauty Inc (NYSE: ELF) rose sharply in pre-market trading after beating analyst expectations with fourth-quarter earnings of 32 cents per share and revenue of $449.29 million, up 35%.…
-
5 months ago benzinga.com
Werewolf Therapeutics Q1 EPS $(0.28), Inline
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This is a 30 percent increase over losses of $(0.40) per share from the…
5 months ago globenewswire.com
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
WATERTOWN, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of…
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
7 months ago benzinga.com
Earnings Scheduled For March 27, 2026
Earnings Scheduled For March 27, 2026
-
7 months ago benzinga.com
Werewolf Therapeutics Q4 EPS $(0.20) Beats $(0.35) Estimate
Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.35) by 43.18 percent. This is a 56.52 percent increase over losses…
7 months ago globenewswire.com
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Company continues to evaluate strategic options to maximize shareholder value Company continues to evaluate strategic options to maximize shareholder value
-
8 months ago benzinga.com
Werewolf Therapeutics Mulls Strategic Options
Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the "Company" or "Werewolf"), an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune…
8 months ago globenewswire.com
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
WATERTOWN, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the “Company” or “Werewolf”), an innovative biopharmaceutical company pioneering the development of…
8 months ago defenseworld.net
Analysts Set Werewolf Therapeutics, Inc. (NASDAQ:HOWL) PT at $3.75
Shares of Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) have earned a consensus recommendation of "Hold" from the seven research firms that are presently covering the firm, Marketbeat…
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
9 months ago defenseworld.net
Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ: HOWL - Get Free Report) Director Luke Evnin sold 24,678 shares of the firm's stock in a transaction that occurred on Friday, January 9th. The shares were sold at…
-
10 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Werewolf Therapeutics, Lowers Price Target to $4
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and lowers the price target from $10 to $4.
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
3 years ago benzinga.com
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.